Arena Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 11 - 20 of about 76   

Articles published

ARNA 4.77 -0.08 (-1.65%)
price chart
Arena Gives Pipeline Exposure - Is The Company Partner Shopping? (ARNA)
Arena Pharmaceuticals (NASDAQ:ARNA) has announced that it was granted U.S. Patent No. 8,778,950, entitled "Cannabinoid Receptor Modulators" by the United States Patent and Trademark Office, for APD371, an agonist of the cannabinoid receptor 2 ...
Morning Alert - Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Achillion ...  Techsonian (press release)
Today's Stocks: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Marvell ...  Markets Insider
Related articles »  
Eye-Catching Stocks � Arena Pharmaceuticals, Inc.(NASDAQ:ARNA), EXCO ...
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) decreased -0.58% at the price of $4.85 recently on a traded volume of 1.84 million shares, in comparison to 5.63 million shares of average trading volume.
Arena Pharmaceuticals Pain Candidate Gets New U.S. Patent
The U.S. Patent and Trademark Office issued a new patent to Arena Pharmaceuticals, Inc. (ARNA - Snapshot Report) for its pain candidate APD371 (U.
Hot Stock List: Arena Pharmaceuticals (NASDAQ:ARNA), Glu Mobile Inc ...
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) announced that it will provide a corporate update and report second quarter 2014 financial results before the NASDAQ Global Select Market opens on Friday, August 1, 2014.
Related articles »  
Arena Pharmaceuticals-Eisai Boost Obesity Drug Sales Force
Arena Pharmaceuticals, Inc. (ARNA - Snapshot Report) announced that partner Eisai Inc. (ESALY) has increased the sales force of their obesity drug, Belviq, by 50% to approximately 600.
Hot Stocks - Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Opko Health Inc ...  Techsonian (press release)
Traders Buzz: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), DARA ...  Market News Call
Related articles »  
Big Movers � First Solar, Inc. (NASDAQ:FSLR), Arena Pharmaceuticals ...
On JULY 21, Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) announced that its wholly owned subsidiary, Arena Pharmaceuticals GmbH, has entered into an exclusive marketing and supply agreement for BELVIQ� (lorcaserin HCl) with Teva Pharmaceutical ...
Related articles »  
News Recap-Infinera Corp. (INFN), Hecla Mining Company (NYSE:HL), Arena ...
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)was at $4.77, showing a -1.65% decrease. Around 2.75 million shares have been traded, versus an-average trading volume of 5.46 M shares.
Related articles »  
Morning Alert -Arena Pharmaceuticals, Inc. (ARNA, Office Depot Inc (ODP ...
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) declared that its wholly owned subsidiary, Arena Pharmaceuticals GmbH, has entered into an exclusive marketing and supply agreement for BELVIQ� (lorcaserin HCl) with Teva Pharmaceutical Industries ...
News Recap: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Geron Corporation ...
Lakeway, NY - (MARKET NEWS CALL) - 7/22/2014� Specialpennystockalert.com, an investment community with a special focus on updating investors with recent news on the U.S.
Movers to Watch - Arena Pharmaceuticals, Inc. (ARNA),Celgene Corporation ...
Arena Pharmaceuticals, Inc.(NASDAQ:ARNA) gaining 2.91% and closed at $4.95 on a traded volume of 5.21 million shares, in comparison to 5.75 million shares of average trading volume.
Traders Favorite: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Lexicon ...  Market News Call
Healthcare Active Runners: Arena Pharmaceuticals (NASDAQ:ARNA), HCA ...  WallStreet Scope
Related articles »